Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protecting the health of the public--Institute of Medicine recommendations on drug safety.

× No keyword cloud information.

17 in total

1. A pharmacoepidemiological network model for drug safety surveillance: statins and rhabdomyolysis.

Authors: Ben Y Reis; Karen L Olson; Lu Tian; Rhonda L Bohn; John S Brownstein; Peter J Park; Mark J Cziraky; Marcus D Wilson; Kenneth D Mandl
Journal: Drug Saf Date: 2012-05-01 Impact factor: 5.606

2. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.

Authors: Peter G M Mol; Sabine M J M Straus; Sigrid Piening; Jonie T N de Vries; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Journal: Drug Saf Date: 2010-06-01 Impact factor: 5.606

3. Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients.

Authors: John Hsu; Vicki Fung; Jie Huang; Mary Price; Richard Brand; Rita Hui; Bruce Fireman; William H Dow; John Bertko; Joseph P Newhouse
Journal: Health Aff (Millwood) Date: 2010-10-28 Impact factor: 6.301

4. Food and Drug Administration.

Authors: Linda R Horton
Journal: BMJ Date: 2007-01-13

5. Rosiglitazone and implications for pharmacovigilance.

Authors: Dhruv Kazi
Journal: BMJ Date: 2007-06-16

6. Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?

Authors: Russell G Thornton
Journal: Proc (Bayl Univ Med Cent) Date: 2008-01

7. Safety-related regulatory actions for orphan drugs in the US and EU: a cohort study.

Authors: Harald E Heemstra; Thijs J Giezen; Aukje K Mantel-Teeuwisse; Remco L A de Vrueh; Hubert G M Leufkens
Journal: Drug Saf Date: 2010-02-01 Impact factor: 5.606

8. Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Authors: Jenny E Blau; Sri Harsha Tella; Simeon I Taylor; Kristina I Rother
Journal: Diabetes Metab Res Rev Date: 2017-09-29 Impact factor: 4.876

Review 9. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?

Authors: Preciosa M Coloma; Gianluca Trifirò; Vaishali Patadia; Miriam Sturkenboom
Journal: Drug Saf Date: 2013-03 Impact factor: 5.606

10. Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients.

Authors: Bradley D Freeman; David J Dixon; Craig M Coopersmith; Barbara A Zehnbauer; Timothy G Buchman
Journal: Pharmacoepidemiol Drug Saf Date: 2008-10 Impact factor: 2.890